Fluorescence in situ hybridization investigation of cutaneous lesions in acute promyelocytic leukemia

Modern Pathology

Volumn 18, Issue 12, 2005, Pages 1569-1576

  Wrede, Joanna E ^a   Sundram, Uma ^a   Kohler, Sabine ^a   Cherry, Athena M ^a   Arber, Daniel A ^a   George, Tracy I ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROMYELOCYTIC LEUKEMIA PROTEIN; RETINOIC ACID;

ADOLESCENT; ADULT; ARTICLE; BLAST CELL; BONE MARROW; CANCER PATIENT; CASE REPORT; CELL INFILTRATION; CELL NUCLEUS; CHROMOSOME REARRANGEMENT; CONTROLLED STUDY; CYTOGENETICS; DERMIS; EPIDERMIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; MALE; MOLECULAR PROBE; MORPHOLOGY; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RETROSPECTIVE STUDY; SCROTUM; SKIN BIOPSY; SKIN DEFECT; SKIN MANIFESTATION;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW CELLS; CHROMOSOMES, HUMAN, PAIR 15; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INTERPHASE; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PARAFFIN EMBEDDING; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TRANSLOCATION, GENETIC;

EID: 27944482233     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800465     Document Type: Article

References (33)

1. Brunning RD, Matutes E, Flandrin G, et al. Acute myeloid leukaemia with recurrent genetic abnormalities. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds). Tumours of Haematopoietic and Lymphoid Tissues. IARC Press: Lyon, France, 2001, pp 81-87.
2. Caligiuri MA, Strout MP, Gilliland DG. Molecular biology of acute myeloid leukemia. Semin Oncol 1997;24:32-44.
3. de The H, Chomienne C, Lanotte M, et al. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 1990;347:558-561.
4. Melnick A, Licht JD. Deconstructing a disease: RAR-alpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia. Blood 1999;93:3167-3215.
5. Falanga A, Rickles FR. Pathogenesis and management of the bleeding diathesis in acute promyelocytic leukaemia. Best Pract Res Clin Haematol 2003;16:463-482.
6. Rives S, Camos M, Bosch F, et al. Central nervous system involvement in acute promyelocytic leukemia. A description of two cases and review of the literature. Haematologica 1999;84:473-474.
7. Sanz MA, Larrea L, Sanz GF, et al. Cutaneous promyelocytic sarcoma at sites of vascular access and marrow aspiration. A characteristic localization of chloromas in acute promyelocytic leukemia? Haematologica 2000;85:758-762.
8. Wiernik PH, De Bellis R, Muxi P, et al. Extramedullary acute promyelocytic leukemia. Cancer 1996;78:2510-2514.
9. Paternoster SF, Brockman SR, McClure RF, et al. A new method to extract nuclei from paraffin-embedded tissue to study lymphomas using interphase fluorescence in situ hybridization. Am J Pathol 2002;160:1967-1972.
10. Esser AC, Nossa R, Shoji T, et al. All-trans-retinoic acid-induced scrotal ulcerations in a patient with acute promyelocytic leukemia. J Am Acad Dermatol 2000;43:316-317.
11. Simzar S, Rotunda AM, Craft N. Scrotal ulceration as a consequence of all-trans-retinoic acid (ATRA) for the treatment of acute promyelocytic leukemia. J Drugs Dermatol 2005;4:231-232.
12. Mourad YA, Jabr F, Salem Z. Scrotal ulceration induced by all-trans retinoic acid in a patient with acute promyelocytic leukemia. Int J Dermatol 2005;44:68-69.
13. Gettinger S, Shapira I, Scheinfeld N, et al. Complications of therapy in cancer patients: case 2. Scrotal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia. J Clin Oncol 2004;22:4648-4649.
14. Paydas S. Scrotal ulceration associated with ATRA. Am J Hematol 2004;77:206-207.
15. Pavithran K, Arjun R, Aruna R, et al. Scrotal ulceration during induction therapy of acute promyelocytic leukemia with ATRA. Am J Hematol 2004;75:260-261.
16. Fukuno K, Tsurumi H, Goto H, et al. Genital ulcers during treatment with ALL-trans retinoic acid for acute promyelocytic leukemia. Leu Lymphoma 2003;44:2009-2013.
17. Charles KS, Kanaa M, Winfield DA, et al. Scrotal ulceration during all-trans retinoic (ATRA) therapy for acute promyelocytic leukaemia. Clin Lab Haematol 2000;22:171-174.
18. Brockman SR, Paternoster SF, Ketterling RP, et al. New highly sensitive fluorescence in situ hybridization method to detect PML/RARA fusion in acute promyelocytic leukemia. Cancer Genet Cytogenet 2003;145:144-151.
19. Astudillo L, Loche F, Reynish W, et al. Sweet's syndrome associated with retinoic acid syndrome in a patient with promyelocytic leukemia. Ann Hematol 2002;81:111-114.
20. Park CJ, Bae YD, Choi JY, et al. Sweet's syndrome during treatment of acute promyelocytic leukemia with all-trans retinoic acid. Korean J Intern Med 2001;16:218-221.
21. Al-Saad K, Khanani MF, Naqvi A, et al. Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol 2004;26:197-199.
22. Takada S, Matumoto K, Sakura T, et al. Sweet's syndrome followed by retinoic acid syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid. Int J Hematol 1999;70:26-29.
23. Levi I, Raanani P, Shalmon B, et al. Acute neutrophilic dermatosis induced by all-trans retinoic acid treatment for acute promyelocytic leukemia. Leuk Lymphoma 1999;34:401-404.
24. Arun B, Berberian B, Azumi N, et al. Sweet's syndrome during treatment with all-trans retinoic acid in a patient with acute promyelocytic leukemia. Leuk Lymphoma 1998;31:613-615.
25. Hatake K, Uwai M, Ohtsuki T, et al. Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management. Int J Hematol 1997;66:13-19.
26. Christ E, Linka A, Jacky E, et al. Sweet's syndrome involving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia 1996;10:731-734.
27. Shirono K, Kiyofuji C, Tsuda H. Sweet's syndrome in a patient with acute promyelocytic leukemia during treatment with all-trans retinoic acid. Int J Hematol 1995;62:183-187.
28. Tomas JF, Escudero A, Fernandez-Ranada JM. All-trans retinoic acid treatment and Sweet syndrome. Leukemia 1994;8:1596.
29. Cox NH, O'Brien HA. Sweet's syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol 1994;19:51-52.
30. Frankel S, Weiss M, Warrel Jr RP. A 'retinoic acid syndrome' in acute promyelocytic leukemia: reversal by corticosteroids. Blood 1991;78(Suppl):380a.
31. Paydas S, Yavuz S, Disel U, et al. Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia. Leuk Lymphoma 2003;44:547-548.
32. van der Vliet HJJ, Roberson AE, Hogan MC, et al. All-trans-retinoic acid-induced myositis: a description of two patients. Am J Hematol 2000;63:94-98.
33. Piette WW, Trapp JF, O'Donnell MJ, et al. Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol 1994;30:293-297.